Cara Lwin
Advisor: Amber Hackstadt
BS, Microbiology (minors in Chemistry, Computer Science, Neuroscience, and Economics), University of Pittsburgh
At Vanderbilt University Medical Center since 2022. Currently Biostatistician.
Activities include:
- Biostatistics Graduate Student Association Vice President, 2021–2022
Publications include:
- "Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults" (JAMA Network Open 2024)
- "Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024" (Morbidity and Mortality Weekly Report 2024, as a member of "CDC COVID-19 Vaccine Effective Collaborators")
- "Neuropathy target esterase activity predicts retinopathy among PNPLA6 disorders" (preprint at bioRxiv 2023)
- "LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates" (Journal of Cheminformatics 2020)
- "Genetic testing for inherited eye conditions in over 6,000 individuals through the eyeGENE network" (American Journal of Medical Genetics, Part C 2020)
Research Information
MS thesis abstract:
This study uses a Bayesian approach and survival models to analyze a large observational data set obtained from electronic health records. We model the association between DPP4 and SGLT2 diabetes therapies and major adverse cardiovascular events. The Bayesian approach allows us to incorporate information from previous studies and obtain credible intervals. Credible intervals allow us to make probability statements when discussing the parameters of interest. To address the lack of randomization, we implement propensity score matching using the nearest-neighbor approach and a caliper. We compare the traditional Cox proportional hazards model to three Bayesian survival models: one with an uninformative prior, one with a prior derived from a metaanalysis of previous trials, and one with a prior having a small variance. We compare results by looking at common estimates of interest, including the survival function, hazard ratio, and restricted mean survival time. We found that a Bayesian model with an uninformative prior has similar results to the Cox proportional hazards model. Models with informative priors are an effective way to incorporate clinical knowledge but note that the variance of the prior should be considered carefully.